-+ 0.00%
-+ 0.00%
-+ 0.00%

MacroGenics sells GMP manufacturing operations to Bora for $122.5 million upfront payment

PUBT·05/11/2026 21:21:05
Listen to the news
MacroGenics sells GMP manufacturing operations to Bora for $122.5 million upfront payment
  • MacroGenics agreed to sell its GMP drug substance manufacturing operations to Bora Pharmaceuticals for USD 122.5 million upfront.
  • Deal transfers Rockville, Maryland manufacturing site, including FDA-approved 11,000-liter capacity facility, plus Frederick, Maryland warehouse; Bora expects to hire about 140 employees.
  • MacroGenics will retain access via a supply arrangement with Bora for process development and drug substance production for its pipeline.
  • Closing expected in Q3 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MacroGenics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605111720PRIMZONEFULLFEED9717853) on May 11, 2026, and is solely responsible for the information contained therein.